The Hyper IgM Foundation is proud to announce the availability of $100,000 in grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome. The intent of these grants is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on new approaches for curative treatment or significant improvement of existing treatments for Hyper IgM Syndrome aimed at reducing mortality and morbidity and improving quality of life.
During the 2022 calendar year, the Hyper IgM Foundation will be awarding one-time grants of up to $100,000 to worthy recipients. Grant applications for 2022 grants have a submission deadline of May 15th, 2022.
Complete and relevant proposals will be reviewed by the Hyper IgM Foundation’s Research Committee (RC), which may solicit feedback from members of the Hyper IgM Foundation’s Scientific Advisory Committee. Any conflicts of interest will be disclosed in the review minutes and will be reported on grant approvals.
Grants may be approved for less than the full amount announced and/or requested. Grants may be split into two or more payments based on agreed-upon goals met for continued funding.
For more information about grants, submissions see their Research Grants page.
All inquiries should be submitted to the Hyper IgM Foundation by contacting email@example.com.
Hyper IgM Foundation
215 W101st Street. Suite 7B
New York, NY 10025
United States of America